Human d-lactate dehydrogenase deficiency by LDHD mutation in a patient with neurological manifestations and mitochondrial complex IV deficiency
- PMID: 34258137
- PMCID: PMC8260477
- DOI: 10.1002/jmd2.12220
Human d-lactate dehydrogenase deficiency by LDHD mutation in a patient with neurological manifestations and mitochondrial complex IV deficiency
Abstract
Background: d-lactate, one of the isomers of lactate, exists in a low concentration in healthy individuals and it can be oxidized to pyruvate catalyzed by d-lactate dehydrogenase. Excessive amount of d-lactate causes d-lactate acidosis associated with neurological manifestations.
Methods and results: We report here a patient with developmental delay, cerebellar ataxia, and transient hepatomegaly. Enzyme analysis in the patient's skin fibroblast showed decreased mitochondrial complex IV activity. Using whole exome sequencing, we identified compound heterozygous variants in the LDHD gene, which encodes the d-lactate dehydrogenase, consisting of a splice site variant c.469+1dupG and a missense variant c.752C>T, p.(Thr251Met) which are pathogenic and likely pathogenic respectively according to the American College of Medical Genetics and Genomics (ACMG) classification. The serum d-lactate level was subsequently detected to be elevated (0.61 mmol/L, reference value: 0-0.25 mmol/L).
Conclusion: This is the third report on LDHD mutations associated with d-lactate elevation and was first reported to have decreased mitochondrial complex IV activity. The study provides more information on this rare metabolic condition but the association of LDHD deficiency with the clinical presentations requires further investigations.
Keywords: LDHD; ataxia; complex IV deficiency; developmental delay; d‐lactate dehydrogenase; neurological.
© 2021 The Authors. JIMD Reports published by John Wiley & Sons Ltd on behalf of SSIEM.
Conflict of interest statement
J. S. is the CEO of Khondrion, a pharmaceutical company developing compounds to potentially treat mitochondrial disease. All the other authors declare that they have no conflict of interest.
Figures

References
-
- Talasniemi JP, Pennanen S, Savolainen H, Niskanen L, Liesivuori J. Analytical investigation: assay of D‐lactate in diabetic plasma and urine. Clin Biochem. 2008;41(13):1099‐1103. - PubMed
-
- Ewaschuk JB, Naylor JM, Zello GA. D‐lactate in human and ruminant metabolism. J Nutr. 2005;135(7):1619‐1625. - PubMed
-
- Chelstowska A, Liu Z, Jia Y, Amberg D, Butow R. Signalling between mitochondria and the nucleus regulates the expression of a new D‐lactate dehydrogenase activity in yeast. Yeast. 1999;15:1377‐1391. - PubMed
-
- Olson ST, Massey V. Purification and properties of the flavoenzyme D‐lactate dehydrogenase from Megasphaera elsdenii . Biochemistry. 1979;18(21):4714‐4724. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources